Page last updated: 2024-09-03

caprylates and efipladib

caprylates has been researched along with efipladib in 1 studies

Compound Research Comparison

Studies (caprylates)	Trials (caprylates)	Recent Studies (post-2010) (caprylates)	Studies (efipladib)	Trials (efipladib)	Recent Studies (post-2010) (efipladib)
5,061	100	2,339	8	0	3

Protein Interaction Comparison

Protein	Taxonomy	caprylates (IC50)	efipladib (IC50)
Cytosolic phospholipase A2	Homo sapiens (human)		0.0203

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babakhani, A; Burke, JE; Dennis, EA; Gorfe, AA; Kokotos, G; Li, S; McCammon, JA; Woods, VL	1

Other Studies

1 other study(ies) available for caprylates and efipladib

Article	Year
Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry. Journal of the American Chemical Society, 2009, Jun-17, Volume: 131, Issue:23 Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Binding Sites; Caprylates; Deuterium; Deuterium Exchange Measurement; Drug Design; Enzyme Inhibitors; Group IV Phospholipases A2; Humans; Mass Spectrometry; Models, Molecular; Pyrrolidines; Sulfonamides	2009

Article

Year

Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry.

Journal of the American Chemical Society, 2009, Jun-17, Volume: 131, Issue:23

Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Binding Sites; Caprylates; Deuterium; Deuterium Exchange Measurement; Drug Design; Enzyme Inhibitors; Group IV Phospholipases A2; Humans; Mass Spectrometry; Models, Molecular; Pyrrolidines; Sulfonamides

2009